Bicycle Therapeutics PLC (BCYC)
23.63
+0.54
(+2.34%)
USD |
NASDAQ |
May 08, 16:00
23.63
0.00 (0.00%)
After-Hours: 18:01
Bicycle Therapeutics Total Return Level: 23.09 for May 7, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 07, 2024 | 23.09 |
May 06, 2024 | 23.30 |
May 03, 2024 | 24.58 |
May 02, 2024 | 24.69 |
May 01, 2024 | 24.20 |
April 30, 2024 | 23.45 |
April 29, 2024 | 23.41 |
April 26, 2024 | 22.73 |
April 25, 2024 | 22.52 |
April 24, 2024 | 22.67 |
April 23, 2024 | 22.68 |
April 22, 2024 | 22.57 |
April 19, 2024 | 23.45 |
April 18, 2024 | 24.49 |
April 17, 2024 | 21.82 |
April 16, 2024 | 21.93 |
April 15, 2024 | 21.82 |
April 12, 2024 | 22.30 |
April 11, 2024 | 22.50 |
April 10, 2024 | 22.99 |
April 09, 2024 | 23.07 |
April 08, 2024 | 22.96 |
April 05, 2024 | 22.73 |
April 04, 2024 | 22.61 |
April 03, 2024 | 23.32 |
Date | Value |
---|---|
April 02, 2024 | 23.73 |
April 01, 2024 | 24.25 |
March 28, 2024 | 24.90 |
March 27, 2024 | 24.55 |
March 26, 2024 | 24.53 |
March 25, 2024 | 25.43 |
March 22, 2024 | 25.49 |
March 21, 2024 | 25.85 |
March 20, 2024 | 25.61 |
March 19, 2024 | 24.55 |
March 18, 2024 | 24.12 |
March 15, 2024 | 23.76 |
March 14, 2024 | 22.94 |
March 13, 2024 | 25.55 |
March 12, 2024 | 25.04 |
March 11, 2024 | 23.67 |
March 08, 2024 | 25.35 |
March 07, 2024 | 25.34 |
March 06, 2024 | 24.64 |
March 05, 2024 | 24.66 |
March 04, 2024 | 24.44 |
March 01, 2024 | 25.72 |
February 29, 2024 | 25.09 |
February 28, 2024 | 25.98 |
February 27, 2024 | 26.10 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
6.736
Minimum
Aug 28 2019
61.14
Maximum
Nov 15 2021
23.74
Average
21.74
Median
May 05 2023
Total Return Level Benchmarks
Biodexa Pharmaceuticals Plc | 1.005 |
NuCana PLC | 3.91 |
TC BioPharm (Holdings) PLC | 1.23 |
Adaptimmune Therapeutics PLC | 1.10 |
Autolus Therapeutics PLC | 4.01 |